StockVS

Buda Juice, Inc. (BUDA) Stock Analysis

Consumer Defensive

Buda Juice, Inc.

$8.49

$-0.27 (-3.07%)

Last Updated: May 26, 2026

Price History

Analysis

Company Overview

Buda Juice, Inc. operates within the consumer defensive sector, specifically focusing on the beverages - non-alcoholic industry, which provides a stable revenue stream driven by essential hydration needs and health-conscious consumption trends. The company specializes in the production and distribution of UltraFresh juices, lemonades, limeades, and wellness shots that adhere to a clean-label philosophy by avoiding pasteurization, preservatives, GMOs, and artificial ingredients. This operational model allows the firm to serve a niche market of consumers seeking USDA certified organic, cold-pressed products that maintain nutritional integrity. As of the latest available data, Buda Juice, Inc. holds a market capitalization of $130.67M and generates annual revenue of $12.49M while employing 40 individuals to execute its distribution and production strategies. These valuation and revenue figures indicate that the company operates as a mid-cap entity with a specialized product portfolio, suggesting a position that relies heavily on brand differentiation and organic certification to compete within the broader beverage landscape.

Financial Health

The company reported a revenue of $12.49M and a net income of $3.82M over the trailing twelve months, with an EBITDA standing at $3.92M. The significant gap between the $12.49M revenue and the $3.82M net income reveals a cost structure where operating expenses and taxes consume approximately 69.4% of total sales, leaving a substantial portion for profit generation. While free cash flow is listed as N/A, the company maintains a cash balance of $2.06M against total debt of $814,000, indicating a strong liquidity position without the burden of significant interest obligations. The balance sheet appears conservative rather than leveraged, supported by a debt-to-equity ratio of 21.24 and a current ratio of 5.30. This high current ratio signifies that the company possesses 5.30 times more current assets than current liabilities, ensuring robust short-term liquidity to meet its obligations. Furthermore, the return on equity and return on assets are listed as N/A, which prevents a direct assessment of management effectiveness via these specific metrics but highlights a need to analyze equity utilization through other means given the lack of comprehensive return data.

Valuation Assessment

The trailing twelve-month P/E ratio stands at 47.62, while the forward P/E is N/A, implying that market expectations for future earnings growth are either undefined or not currently priced in by analysts. The price-to-book ratio of 26.11 indicates a substantial market premium over the company's book value, reflecting investor confidence in the brand's intangible assets and organic certification status. Alternative valuation metrics such as the price-to-sales ratio of 10.47 and an EV/EBITDA of 31.95 suggest that the market values the company significantly higher than its current sales and earnings multiples would traditionally imply for a smaller player. Regarding price action, the stock has traded between a 52-week low of $6.85 and a 52-week high of $12.00, with the current price position relative to this range dependent on the real-time trading floor but bounded by these historical extremes. The beta value is listed as N/A, meaning that the stock's historical volatility relative to the broader market index cannot be quantified using this specific metric.

Growth & Income

Revenue growth year-over-year is recorded at 9.1%, whereas earnings growth year-over-year shows a decline of -33.9%, indicating that earnings are currently shrinking faster than revenue, which suggests margin compression or one-time costs impacting profitability. The company does not pay a dividend, as evidenced by a dividend yield of N/A and a payout ratio of 0.0%, meaning the firm reinvests its earnings into growth initiatives, product development, or balance sheet strengthening rather than returning capital to shareholders. This strategy aligns with the company's stage of development where retaining cash is prioritized for expansion within the clean-label beverage market. The overall growth and income profile presents a picture of a growing top line that has recently faced headwinds in profitability, offering no current income stream for investors but potential for capital appreciation if earnings growth normalizes.

Peer Comparison

Buda Juice, Inc. (BUDA) operates in the Beverages - Non-Alcoholic industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Buda Juice, Inc. BUDA $106.70M 34.0
The Coca-Cola Company KO $346.18B 25.3
PepsiCo, Inc. PEP $205.82B 23.6
Monster Beverage Corporation MNST $85.50B 42.2

The Beverages - Non-Alcoholic industry average P/E ratio is 42.7x. Buda Juice, Inc. trades at a P/E of 34.0.

This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.

About Buda Juice, Inc.

Buda Juice, Inc. engages in producing and distributing juice, lemonades, limeades, and wellness shots in the United States. The company offers clean-label beverages; citrus juices; and cold-pressed juices made from fruits and vegetables. The company serves wholesale clients. The company was incorporated in 2013 and is headquartered in Dallas, Texas.

Visit website →

Key Statistics

Market Cap
$106.70M
P/E Ratio
33.96
52-Week High
$12.00
52-Week Low
$6.85
Avg Volume
19.91K

Data provided by Yahoo Finance via yfinance. Updated daily.

Company Info

Exchange
AMEX
Country
United States
Employees
39